**Core Concept:** Schizophrenia is a chronic mental disorder that affects the way a person thinks, feels, and behaves. It is typically treated with antipsychotic medications like risperidone, which block dopamine D2 receptors in the brain, leading to symptom improvement. Treatment duration depends on factors like response to therapy, side effects, and patient compliance.

**Why the Correct Answer is Right:** In this case, the patient has been well-maintained on risperidone for the last 2 months, suggesting a positive response to treatment. The absence of a family history of the disease also indicates that the disorder is likely to be idiopathic (not inherited). Based on the patient's response and the absence of risk factors, we would continue treatment for a reasonable duration to ensure long-term symptom control and minimize the risk of relapse.

**Why Each Wrong Option is Incorrect:**

A. **Short Treatment Duration (2 Months):** While the patient has shown improvement after 2 months, treatment duration cannot be determined solely based on this short period. Treatment should be continued for a sufficient duration to ensure long-term symptom control and minimize relapse risk.

B. **Absence of Family History:** The patient has an idiopathic form of schizophrenia, which means the disorder is likely to be acquired rather than inherited. However, the absence of family history does not warrant a shorter treatment duration.

C. **Long Treatment Duration (Forever):** Treatment duration should be individualized based on the patient's response and risk factors. Simply stating "forever" is not a practical approach for determining the duration of treatment.

D. **Absence of Side Effects:** Side effects should not be the sole basis for deciding treatment duration. While the patient may have tolerated risperidone well, the focus should be on long-term outcomes like symptom control and relapse prevention.

**Clinical Pearl:** Treatment duration for schizophrenia varies widely among patients, depending on factors like response to therapy, side effects, and risk of relapse. A general guideline is to continue antipsychotic treatment indefinitely or until the patient has shown adequate symptom control for at least 6-12 months. However, the patient's response to treatment, side effects, and risk of relapse should be regularly assessed and treatment duration adjusted accordingly.